At Philips Healthcare we combine our unique clinical expertise with human insights to develop meaningful innovations that help to improve the quality of people's lives. We develop solutions that deliver value throughout the care cycle: from disease prevention to screening, treatment, monitoring and health management.
Already a world leader in imaging systems and picture archiving and communication systems (PACS), Philips has established the Digital Pathology venture to develop digital pathology solutions that are designed around the needs of pathologists, easy to use and fit seamlessly into existing workflows.
Over the last ten years, new technology has enabled pathology departments to begin digitizing their work. Based on this trend, Sectra has developed Digital Pathology Solutions for the next generation consisting of a high-end diagnostic viewer, unified integrations, and proven archiving and image handling protocols. With full focus on end-user experience and workflow efficiency, pathologists are able to make their diagnoses and reporting faster and easier through efficient image interaction, access to full case overview any time, from anywhere, as well as easy image sharing for external review and a balanced workload.
With more than 20 years in imaging, Sectra develops andsells IT systems for radiology, pathology, women's health and orthopedics. More than 1,700 hospitals, clinics and imaging centers worldwide use the systems daily, making Sectra one of the world-leading companies for handling digital images. For more information visit www.sectra.com
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the process. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Visiopharm image analysis driven Quantitative Digital Pathology has become the preferred solution for leading biopharmaceutical companies, CROs, academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded with VirtualDoubleStaining™ algorithms for automated tumor identification and Oncotopix® Diagnostics for cancer diagnostics, all of which is for CE-IVD application and works in a LIS driven workflow.
Our software is featured in over 1100 scientific publications, and is compatible with leading slide scanner manufacturers and data management software. Visiopharm has grown into an international business with over 750 licenses and countless more users, in more than 30 countries. Our growing network of authorized distributors and integration partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Our headquarters is located in the Medicon Valley of Denmark and has a North America office in Broomfield, Colorado.